12-year-old boy from Everett underwent the first heart transplant at Children’s Hospital and Regional Medical Center
On Oct. 26, 1994, a 12-year-old boy from Everett underwent the first heart transplant at Children’s Hospital and…
On Oct. 26, 1994, a 12-year-old boy from Everett underwent the first heart transplant at Children’s Hospital and…
On Sept. 8, 1994, ZymoGenetics dedicated Seattle’s historic Lake Union Steam Plant. The renovated 113,000 s.f. plant doubled…
On Aug. 1, 1994, the ZymoGenetics Lake Union Steam Plant and Hydro House were designated City of Seattle…
On Jun. 16, 1994, the University of Washington and ZymoGenetics scientists reported in Nature the discovery, isolation and…
On Apr. 4, 1994, the Washington State Sales Tax Exemption for High Technology R&D/Manufacturing was signed by Governor…
In 1994, Mary-Claire King, PhD, a University of Washington professor of genome sciences and medicine, discovered the “breast…
In 1994, Omeros Corp. was founded in Seattle as a biopharmaceutical company committed to discovering, developing and commercializing…
On Jun. 15, 1983, the Organization of Regulatory and Clinical Associates (ORCA) was founded in Seattle to provide…
On May 13, 1993, ZymoGenetics began a $25 million year-long renovation of the The Seattle City Light Steam…
On Apr. 14, 1993, the Earl Davie/ZymoGenetics Endowed Chair of Biochemistry at the University of Washington was established…
In 1993, The Institute of Medicine published “The Children’s Vaccine Initiative: Achieving the Vision.” The Children’s Vaccine Initiative…
On Dec. 21, 1992, Immunex announced a merger agreement with American Cyanamid Company’s Lederle Oncology business. In Nov….
In 1993, Targeted Genetics, a subsidiary of the Immunex Corporation, became the first company to begin human clinical…
On Oct. 12, 1992, Edmond Fisher and Edwin Krebs of University of Washington’s (UW) School of Medicine received…
On Sept. 3, 1992, PathoGenesis Corp. was founded by Robert Nowinski. The company, based in Seattle, developed an…
On Feb. 28, 1992, Madigan Army Medical Center opened its 1.2 million square foot complex, the newest and…
In 1992, Dendreon was founded, and its lead product, Provenge, was an immunotherapy for prostate cancer. Dendreon filed…
On Oct. 7, 1991, the University of Washington (UW) announced a $12 million gift from Microsoft co-founder Bill…
On Sept. 4, 1991, Cell Therapeutics, also known as CTI BioPharma, was incorporated by two oncologists, Drs. James…
On Aug. 26, 1991, Cellpro announced its initial public offering. CellPro, founded in Bothell, developed the CEPRATE SC…
On Jun. 6, 1991, ICOS completed its IPO at at $8.00 per share for a total of $36…
In March 1991, Immunex announced it had received U.S. Food and Drug Administration (FDA) approval to market Leukine…
On Dec. 8, 1990, E. Donnall Thomas of the Fred Hutchinson Cancer Research Center and Joseph E. Murray…
In 1990, the California Supreme Court rules in the case involving Seattle’s John Moore that a patient does…
On Oct. 10, 1989, ICOS Corp. was founded by Robert Nowinski, Christopher Henney and George Rathmann with $33…
In 1989, the Washington Biotechnology & Biomedical Association, now Life Science Washington, was founded by local biotechnology companies…
In 1989, CellPro was founded in Bothell as a spin-off from the Fred Hutchinson Cancer Research Center. The…
In 1989, H. Stewart Parker became CEO of Targeted Genetics, an Immunex Corp. spin-off in Seattle. which specialized…
On Dec. 16, 1988, the Virginia Merrill Bloedel Hearing Research Center was established through a $7 million gift…
On Jun. 24, 1988, University of Washington hearing researchers published In “Science” the first report of inner ear…